LCTX:NYSEAMERICAN
Lineage Cell Therapeutics Inc
1,32 USD
0,00%
(0,00) 1 D
8. juli, 13:29:22 GMT-4 · USD
search
Alle symboler
1 D
5 D
1 M
6 M
I år
1 Å
5 Å
MAKS
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for LCTX …
Åpne
1,30 USD
Høy
1,34 USD
Lav
1,30 USD
Markedsverdi
329,07 mill.
Snittvolum
1,78 mill.
Volum
595,94k
52 u høy
2,09 USD
52 u lav
0,93 USD
EPS
−0,28 USD
Beta
1,51
Utestående aksjer
249,30 mill.
Antall ansatte
75
Åpne
1,30 USD
Høy
1,34 USD
Lav
1,30 USD
Markedsverdi
329,07 mill.
Snittvolum
1,78 mill.
Volum
595,94k
52 u høy
2,09 USD
52 u lav
0,93 USD
EPS
−0,28 USD
Beta
1,51
Utestående aksjer
249,30 mill.
Antall ansatte
75
Nyhetssaker
Fra kilder på nettet
https://www.dars.gov.et/
·
for 5 døgn siden
LCTX Q1 2026 Earnings: EPS Misses Estimates Despite Positive Stock Reaction - Share Dilution Risk
Profil
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
Om Lineage Cell Therapeutics Inc
AI-innhold kan inneholde feil. Finn ut mer